Unified classification and risk-stratification in Acute Myeloid Leukemia

Yanis Tazi, Juan E. Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean J. Johnson, Robert Hills, Richard Dillon, Max F. Levine, Daniel Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard Adams, Hartmut Döhner, Peter J. Campbell, Alan K. Burnett, Michael Dennis, Nigel H. Russell, Sean M. Devlin, Brian J. P. Huntly and Elli Papaemmanuil ()
Additional contact information
Yanis Tazi: Memorial Sloan Kettering Cancer Center
Juan E. Arango-Ossa: Memorial Sloan Kettering Cancer Center
Yangyu Zhou: Memorial Sloan Kettering Cancer Center
Elsa Bernard: Memorial Sloan Kettering Cancer Center
Ian Thomas: Cardiff University
Amanda Gilkes: Cardiff University
Sylvie Freeman: University of Birmingham
Yoann Pradat: Memorial Sloan Kettering Cancer Center
Sean J. Johnson: Cardiff University
Robert Hills: University of Oxford
Richard Dillon: King’s College
Max F. Levine: Memorial Sloan Kettering Cancer Center
Daniel Leongamornlert: Wellcome Sanger Institute
Adam Butler: Wellcome Sanger Institute
Arnold Ganser: Hannover Medical School
Lars Bullinger: Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
Konstanze Döhner: Ulm University
Oliver Ottmann: Cardiff University
Richard Adams: Cardiff University
Hartmut Döhner: Ulm University
Peter J. Campbell: Wellcome Sanger Institute
Alan K. Burnett: formerly Cardiff University
Michael Dennis: The Christie NHS Foundation Trust
Nigel H. Russell: Nottingham University Hospital
Sean M. Devlin: Memorial Sloan Kettering Cancer Center
Brian J. P. Huntly: University of Cambridge
Elli Papaemmanuil: Memorial Sloan Kettering Cancer Center

Nature Communications, 2022, vol. 13, issue 1, 1-16

Abstract: Abstract Clinical recommendations for Acute Myeloid Leukemia (AML) classification and risk-stratification remain heavily reliant on cytogenetic findings at diagnosis, which are present in

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-32103-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32103-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-32103-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().